Meixi Liu
Peking Union Medical College Hospital
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Letter to the Editor: Comment on "HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk".
Journal: Hepatology (Baltimore, Md.)
Published: November 10, 2020
The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD.
Journal: Journal of hepatology
Published: October 28, 2020
Letter to the editor: prediction of survival in colorectal cancer using artificial intelligence.
Journal: Gut
Published: October 15, 2020
Comparison of Prognostic Value of Red Cell-Related Parameters of Biliary Tract Cancer After Surgical Resection and Integration of a Prognostic Nomogram: A Retrospective Study.
Journal: Advances in therapy
Published: October 07, 2020
Unique TP53 neoantigen and the immune microenvironment in long-term survivors of Hepatocellular carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: April 15, 2020
High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China.
Journal: Cancer research and treatment
Published: April 13, 2020
Albumin binding function is a novel biomarker for early liver damage and disease progression in non-alcoholic fatty liver disease.
Journal: Endocrine
Published: February 20, 2020
Impaired albumin function: a novel potential indicator for liver function damage?
Journal: Annals of medicine
Published: November 13, 2019
Patient-derived organoids: a promising model for personalized cancer treatment.
Journal: Gastroenterology report
Published: July 04, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026